Kate M. Moore

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. John F. Marshall · 3 shared papers, 2019–2021 · strength 0.28
   • Paper CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-19-2163↗
   • Paper Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. DOI 10.7150/thno.38702↗
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
2. Nicholas Fraser Brown · 2 shared papers, 2020–2021 · strength 0.21
   • Paper CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-19-2163↗
   • Paper Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. DOI 10.7150/thno.38702↗
3. Hemant Mahendrakumar Kocher · 2 shared papers, 2019–2021 · strength 0.19
   • Paper CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-19-2163↗
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
4. Claire S. Reader · 2 shared papers, 2019–2020 · strength 0.17
   • Paper Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. DOI 10.7150/thno.38702↗
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
5. Deepak Raj · 1 shared paper, 2021 · strength 0.12
   • Paper CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-19-2163↗
6. Sara Maria David Trabulo · 1 shared paper, 2020 · strength 0.10
   • Paper Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. DOI 10.7150/thno.38702↗
7. Syed Haider · 1 shared paper, 2019 · strength 0.07
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
8. Colin William Steele · 1 shared paper, 2019 · strength 0.07
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
9. Peter J. Bailey · 1 shared paper, 2019 · strength 0.07
   • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
10. Simon T. Barry · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
11. Nigel Balfour Jamieson · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
12. Rita Teresa Lawlor · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
13. Claude Chelala · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
14. Jennifer P. Morton · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
15. David Kuang-Fu Chang · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
16. Owen James Sansom · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
17. Andrew Victor Biankin · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗
18. Aldo Scarpa · 1 shared paper, 2019 · strength 0.07
    • Paper The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. DOI 10.1002/path.5320↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.